← Back to Patent Explorer
US4777139A Expired / Lapsed US ⏱️ 0.0 years remaining

Hematology control or calibrator with red cell components of enhanced stability

Assignee: IL Holding Spa
•
Filing: 1987-06-25
•
Granted: 1988-10-11
•
Expires: 2007-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Red cells are exposed to an unsaturated aldehyde such as acrolein (propenal) under conditions sufficient to increase the stability of the cells without impairing the ability of a lysing reagent to lyse the cells. After treatment, the treated cells are washed and are suspended in a stabilizing suspension medium.

Inventors

  • 👤 Show-Chu Wong
  • 👤 Harbans S. Deol
  • 👤 Debra L. Harz
  • 👤 Jill H. Davidson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 04:19
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/96; G01N2496/00; G01N2496/05; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/107497; Y10T436/108331

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 63 words
A hematology control or calibrator comprising a suspension of treated erythrocytes in a stabilizing medium, characterized by the treated erythrocytes having been exposed to a aliphatic unsaturated aldehyde of 3-6 carbons under conditions sufficient to increase the stability of the treated erythrocytes in the stabilizing medium without impairing the ability of a lysing reagent to lyse the treated erythrocytes in a hematology analyzer.
Claim 2
Dependent Claim 63 words
A hematology control or calibrator comprising a suspension of treated erythrocytes in a stabilizing medium, characterized by the treated erythrocytes having been exposed to a aliphatic unsaturated aldehyde of 3-6 carbons under conditions sufficient to increase the stability of the treated erythrocytes in the stabilizing medium without impairing the ability of a lysing reagent to lyse the treated erythrocytes in a hematology analyzer.
Claim 3
Dependent Claim 15 words
The hematology control or calibrator of claim 1 wherein the aliphatic unsaturated aldehyde is propenal.
Claim 4
Dependent Claim 48 words
The hematology control or calibrator of claim 2 wherein the treated erythrocytes have been exposed to propenal at a concentration of about 0.01% to about 1.0% for a time of about 5 minutes to about 24 hours at a temperature from about 0° C. to about 30° C.
Claim 5
Dependent Claim 29 words
The hematology control or calibrator of claim 3 wherein the temperature is about 20°-25° C., the time is about 1 to 4 hours and the concentration is about 0.02-0.2%.
Claim 6
Dependent Claim 27 words
The hematology control or calibrator of claim 3 wherein the temperature is about 0°-5° C., the time is about 15-30 hours and the concentration is about 0.02-0.2%.
Claim 7
Dependent Claim 90 words
A process for preparing a hematology control or calibrator comprising the steps: (a) exposing washed erythrocytes to an unsaturated aldehyde at a treatment concentration and temperature for a treatment time period, (b) after the treatment time period, washing the treated erythrocytes, and (c) suspending the treated and washed erythrocytes in a stabilizing suspending medium the treatment concentration, temperature and time being sufficient to increase the stability of the treated erythrocytes in suspending medium without impairing the ability of a lysing reagent to lyse the treated erythrocytes in a hematology analyzer.
Claim 8
Dependent Claim 90 words
A process for preparing a hematology control or calibrator comprising the steps: (a) exposing washed erythrocytes to an unsaturated aldehyde at a treatment concentration and temperature for a treatment time period, (b) after the treatment time period, washing the treated erythrocytes, and (c) suspending the treated and washed erythrocytes in a stabilizing suspending medium the treatment concentration, temperature and time being sufficient to increase the stability of the treated erythrocytes in suspending medium without impairing the ability of a lysing reagent to lyse the treated erythrocytes in a hematology analyzer.
Claim 9
Dependent Claim 12 words
The process of claim 6 wherein the aliphatic unsaturated aldehyde is propenal.
Claim 10
Dependent Claim 38 words
The process of claim 7 wherein the treatment concentration is about 0.01% to about 0.5%, the treatment temperature is about 0° C. to about 30° C. and the treatment time is about 5 minutes to about 24 hours.
Claim 11
Dependent Claim 36 words
The process of claim 8 wherein the treatment concentration is about 0.02 to about 0.2%, the treatment temperature is about 20° C. to about 25° C. and the treatment time is about 1 to 4 hours.
Claim 12
Dependent Claim 34 words
The process of claim 8 wherein the treatment concentration is about 0.02% to about 0.2%, the treatment temperature is about 0° C. to about 5° C. and the treatment time is about 15-30 hours.

References Cited (Backward Citations)

US3708572A Cited
US3973913A Cited
US4107287A Cited
US4324687A Cited
US4358394A Cited
US4390632A Cited
US4489162A Cited
US4579824A Cited
US4698312A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-10-11 1992-04-11 1992-10-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-10-11 1996-04-11 1996-10-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-10-11 2000-04-11 2000-10-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag